IL-17 Modulator 4(Cat No.:I045248)is a small-molecule compound designed to modulate the activity of interleukin-17 (IL-17), a pro-inflammatory cytokine implicated in autoimmune and inflammatory diseases. By regulating IL-17 signaling, this modulator can influence downstream pathways such as NF-κB and MAPK, reducing excessive inflammatory responses. It serves as a valuable research tool for studying IL-17–driven pathologies, including psoriasis, rheumatoid arthritis, ankylosing spondylitis, and other chronic inflammatory conditions. IL-17 Modulator 4’s potency, selectivity, and suitability for cell-based assays make it an important agent for investigating cytokine-targeted therapeutic strategies.